IMPROV (Improving the Radical Cure of Vivax Malaria)

NCT01814683 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

2388

Enrollment

OTHER

Sponsor class

Conditions

Uncomplicated Vivax Malaria

Interventions

DRUG: Primaquine
DRUG: Primaquine
DRUG: Placebo

Sponsor

University of Oxford

Collaborators

[object Object]